Zobrazeno 1 - 10
of 73
pro vyhledávání: '"A. J. Muñoz-Martín"'
Autor:
Javier Soto Alsar, Roberto Jiménez Rodríguez, Ana Gutiérrez, Laura Ortega Morán, Andrés J. Muñoz Martín
Publikováno v:
Thrombosis Update, Vol 16, Iss , Pp 100183- (2024)
Cancer-associated thrombosis is a common problem in cancer patients and one of the leading causes of death in this population. Randomised clinical trials have shown that both low-molecular-weight heparins and direct oral anticoagulants are the treatm
Externí odkaz:
https://doaj.org/article/c0f5d63703ca4aa9a6317998b2f96000
Autor:
Manuel Sánchez-Cánovas, Paula Jimenez-Fonseca, David Fernández Garay, Mónica Cejuela Solís, Diego Casado Elía, Eva Coma Salvans, Irma de la Haba Vacas, David Gómez Sánchez, Ana Fernández Montés, Roberto Morales Giménez, Mercedes Biosca Gómez de Tejada, Virginia Arrazubi Arrula, Silvia Sequero López, Remedios Otero Candelera, Cristina Sánchez Cendra, Marina Justo de la Peña, Diana Moreno Muñoz, Mayra Orillo Sarmiento, Eva Martínez de Castro, Ignacio García Escobar, Alejandro Bernal Vidal, Laura Ortega Moran, Andrés J Muñoz Martín, Rodrigo Sánchez Bayona, María José Martínez Ortiz, Francisco Ayala de la Peña, Vicente Vicente, Alberto Carmona-Bayonas
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0266305 (2023)
IntroductionThere is currently no validated score capable of classifying cancer-associated pulmonary embolism (PE) in its full spectrum of severity. This study has validated the EPIPHANY Index, a new tool to predict serious complications in cancer pa
Externí odkaz:
https://doaj.org/article/42dc26c8c9044eb8a81ba6d19eb1f0d0
Autor:
Silvia García Adrián, Adán Rodríguez González, Eva Martínez de Castro, Vanessa Pachón Olmos, Laura Ortega Morán, Purificación Martínez del Prado, Mercedes Salgado Fernández, José David Cumplido Burón, Ignacio García Escobar, Joaquina Martínez Galán, Ana Isabel Ferrer Pérez, Fernando Neria, Diego Cacho Lavin, Borja López de San Vicente Hernández, Paula Jiménez-Fonseca, Andrés J. Muñoz Martín
Publikováno v:
European Journal of Internal Medicine. 105:30-37
Background Pancreatic carcinoma is one of the tumors associated with a higher risk for thromboembolic events, with incidence rates ranging from 5% to 41% in previous retrospective series. Patients and methods We conducted a retrospective study in ele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49cacca2eacab8c10ac6de70f8d57bc7
https://doi.org/10.1016/j.ejim.2022.07.020
https://doi.org/10.1016/j.ejim.2022.07.020
Publikováno v:
Best practiceresearch. Clinical haematology. 35(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eed878e8d234c1614dc77da6917cb52a
https://pubmed.ncbi.nlm.nih.gov/36030070
https://pubmed.ncbi.nlm.nih.gov/36030070
Autor:
Lorena Martin Roman, Jose Manuel Asencio Pascual, Pilar García-Alfonso, Alvaro Gregorio Morales Taboada, Jose Antonio Blanco Rodriguez, Pablo Lozano Lominchar, Andres J. Muñoz Martín
Publikováno v:
Annals of Hepato-Biliary-Pancreatic Surgery
In the last two decades, pancreatic cancer has been undergoing important changes in its perioperative management due to the great interest in multidisciplinary management and preoperative multimodal therapy, which in numerous studies have shown promi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20a4fb8504ab9023739ba5ba5ce19c3
https://doi.org/10.14701/ahbps.2021.25.2.179
https://doi.org/10.14701/ahbps.2021.25.2.179
Autor:
Javier Soto Alsar, Ana Gutiérrez Ortiz de la Tabla, Laura Ortega Morán, Andrés J. Muñoz Martín
Publikováno v:
Best practiceresearch. Clinical haematology. 35(1)
Anticoagulation is the cornerstone of cancer-associated VTE treatment, including vitamin K antagonists (VKA), unfractionated heparin (UFH), fondaparinux, low-molecular-weight heparins (LMWH) and direct oral anticoagulants (DOACs). The goals of antico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05de31fc0b62769a6e482d2a62f7990
https://pubmed.ncbi.nlm.nih.gov/36030074
https://pubmed.ncbi.nlm.nih.gov/36030074
Autor:
Manuel Sánchez-Cánovas, Paula Jimenez-Fonseca, David Fernández Garay, Mónica Cejuela Solís, Diego Casado Elía, Eva Coma Salvans, Irma de la Haba Vacas, David Gómez Sánchez, Ana Fernández Montés, Roberto Morales Giménez, Mercedes Biosca Gómez de Tejada, Virginia Arrazubi Arrula, Silvia Sequero López, Remedios Otero Candelera, Cristina Sánchez Cendra, Marina Justo de la Peña, Diana Moreno Muñoz, Mayra Orillo Sarmiento, Eva Martínez de Castro, Ignacio García Escobar, Alejandro Bernal Vidal, Laura Ortega Moran, Andrés J. Muñoz Martín, Rodrigo Sánchez Bayona, María José Martínez Ortiz, Francisco Ayala de la Peña, Vicente Vicente, Alberto Carmona-Bayonas
IntroductionThere is currently no validated score capable of classifying cancer-associated pulmonary embolism (PE) in its full spectrum of severity. This study has validated the EPIHANY Index, a new tool to predict serious complications in cancer pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9065da72df84b0b9bd9fcad1b669e077
https://doi.org/10.1101/2022.03.28.22272682
https://doi.org/10.1101/2022.03.28.22272682
Autor:
Ignacio García Escobar, María Carmen Viñuela Benéitez, Andres J. Muñoz Martín, José Manuel Soria Fernández, Sara Perez Ramirez, Magdalena Carmen Ruiz Zamorano, Laura Ortega Morán, Inmaculada Aparicio Salcedo
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
Risk factors for cancer-associated thrombosis are commonly divided into three categories: patient-, cancer-, and treatment-related factors. Currently, different types of drugs are used in cancer treatment. Chemotherapy has been identified as an indep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b124bdc1bf43bca3fd1ac2f0254fef1
http://europepmc.org/articles/PMC7189737
http://europepmc.org/articles/PMC7189737
Autor:
Silvia García Adrián, Vanessa Pachón Olmos, Purificación Martínez del Prado, Andrés J. Muñoz Martín
Publikováno v:
European Journal of Internal Medicine. 109:116
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb60760e7cf0a61027c7623116dfb1e3
https://doi.org/10.1016/j.ejim.2023.01.013
https://doi.org/10.1016/j.ejim.2023.01.013
Autor:
Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Rocío Martín Lozano, Manuel Alva Bianchi, Mónica Benavente de Lucas, María Palma Gómez, Marc Ariant Cañete Muñoz, Bárbara Lobato Delgado, Victoria Tirado Anula, Blanca Morón García, Magdalena Ruiz Zamorano, Ivan Marquez-Rodas, Isabel Echavarria Diaz Guardamino, Gabriela Torres Pérez-Solero, Aitana Calvo Ferrándiz, Laura Ortega, Jose Manuel Soria, Pilar Garcia-Alfonso, Miguel Martin, Andrés J. Muñoz Martín
Publikováno v:
Journal of Clinical Oncology. 41:670-670
670 Background: Pancreatic Ductal Adenocarcinoma (PDAC) has historically been an important diagnostic and therapeutic challenge. The multidisciplinary approach and new diagnostic techniques’ implementation have modified this process. Methods: We co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7e993cd6ebdd6333d92e020f19e1e6b
https://doi.org/10.1200/jco.2023.41.4_suppl.670
https://doi.org/10.1200/jco.2023.41.4_suppl.670